At Nagi Bioscience, we deliver the world’s first automated in vivo solution to simultaneously measure lifespan, healthspan, and biological age in a single, streamlined workflow. We are the partner of choice for biotech, nutraceutical, and pharmaceutical companies developing the future of aging and longevity interventions. Trusted globally, we combine Swiss-engineered precision with over 15 years of expertise in aging biology, supporting leading innovators in bringing life-changing interventions to society, faster.
| Website | http://nagibio.ch/ |
| Revenue | $8.2 million |
| Employees | 54 (26 on RocketReach) |
| Founded | 2019 |
| Address | Rue des Jordils 1a, EPFL Innovation Park, Building M, Saint-Sulpice, Vaud 1025, CH |
| Phone | +41 21 693 48 34 |
| Technologies |
JavaScript
,
HTML
,
PHP
+17 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Science and Engineering |
| Keywords | Animal Testing Alternatives, In Vitro Testing, Nextgen Technology, Laboratory Equipment, Scientific Instruments, Lab Automation, High Throughput Screening, Alternative Methods, Biotechnology, Precision Instruments, Research Technology, Drug Discovery, Bioscience, Advanced Testing, Pharmaceutical Research, Medical Technology, Cell Biology, Toxicology, In Vivo Testing |
| Competitors | Thermo Fisher Scientific, Illumina, Icahn School of Medicine at Mount Sinai, QIAGEN, Benchling, Twist Bioscience, PacBio, Synthego Corporation, Zymergen, Inc., DNA Script +29 more (view full list) |
Looking for a particular Nagi Bioscience employee's phone or email?
The Nagi Bioscience annual revenue was $8.2 million in 2026.
Matteo Cornaglia is the CEO and founder of Nagi Bioscience.
26 people are employed at Nagi Bioscience.
Nagi Bioscience is based in Saint-Sulpice, Vaud.